| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-11 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.4 | 5e-09 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |